相关实验视频

Updated: May 24, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

用蓝色激光蒸发治疗良性前列腺增生症的性功能:一项前性研究

Zun-Jie Hu¹, Fei Liu¹, Bing-Hui Li²

¹Department of Urology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.

The aging male : the official journal of the International Society for the Study of the Aging Male

|March 4, 2025

概括

蓝色激光蒸发有效地治疗良性前列腺增生症 (BPH) 症状. 这种新的BPH治疗方法可以保持患者的性功能,包括勃起和射精能力.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
最少侵入性的手术
性健康性的健康

背景情况:

对于接受良性前列腺增生 (BPH) 手术的患者来说,保持性功能至关重要.
蓝色激光蒸发是一种新的BPH治疗方法,对其性功能结果的数据有限.

研究的目的:

评估蓝色激光蒸发对BPH患者性功能的影响.
评估BPH治疗后患者报告的性功能结果.

主要方法:

对67名BPH患者进行蓝色激光蒸发的前性研究.
使用的标准化调查问卷:IIEF-5,MSHQ-EjD,ICIQ-MLUTS,以及ICIQ-MLUTSsex. 这三种问卷.
在手术后,监测患者超过三个月.

主要成果:

蓝色激光蒸发显著改善了BPH症状 (IPSS,QoL,ICIQ-MLUTS) 并减少了空白后的残留体积 (p < 0.001).
没有观察到勃起功能 (IIEF-5),射精功能 (MSHQ-EjD) 或相关性功能得分 (ICIQ-MLUTSex) 的显著变化.

结论:

蓝色激光蒸发在缓解BPH患者下尿路症状方面是有效的.
这种BPH手术技术证明了勃起和射精功能的保存.

关键词:

450纳米的蓝色激光器良性前列腺增生症良性前列腺增生症队列研究是一项队列研究.性功能性功能性功能性功能性功能性功能蒸发是蒸发的过程.

更多相关视频

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...